KFDA approved 3 orphan drugs.

Published: 1999-10-18 13:15:00

Updated: 1999-10-18 13:15:00

The KFDA recently approved 3 orphan drugs, Temozolomide (an anticancer drug), Interferon beta-1a (drug for a multiple sclerosis) and Trustjumap ( HER2 :human epidermal growth factor receptor 2 protein, for a breast cancer, and now the total number of orphan drugs approved by the KFDA 159 products...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK